학술논문
Comment of an Expert Group of the Paul-Ehrlich-Society for Chemotherapy on the benefit assessment of fidaxomicin for treatment of Clostridium difficile infections
Document Type
article
Author
Source
GMS Infectious Diseases, Vol 1, p Doc07 (2013)
Subject
Language
English
ISSN
2195-8831